Bioprocess Bags Market - Databook 2025 to 2034

The global bioprocess bags market size accounted for USD 4,050 million in 2024 and is predicted to touch around USD 18,650 million by 2034, growing at a CAGR of 16.5% from 2025 to 2034.

Highlights of the Bioprocess Bags Market  

• North America dominated the global market in 2024.  
• Asia Pacific is predicted to witness significant growth in the market over the forecast period.  
• By type, the 2D bioprocess bags segment accounted for a considerable share of the market in 2024.  
• By type, the 3D bioprocess bags segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.  
• By workflow, the upstream process segment registered its dominance over the global market in 2024.  
• By workflow, the downstream process segment will gain a significant share of the market over the studied period of 2025 to 2034.  
• By end user, the pharmaceutical & biopharmaceutical companies segment held a dominant presence in the market in 2024.  
• By end user, the CMOs & CROs segment is anticipated to grow with the highest CAGR in the market during the studied years.  

Industry Valuation and Growth Rate Projection

The bioprocess bags market takes care of bioprocessing bags, also known as bioprocess containers or BPCs. These are single-use, flexible, and customizable containers used to carry fluids and materials like media, pharmaceutical drugs, and vaccines, surrounded by a bioprocess environment in a safe manner. These bags are mainly used in the biotechnology and biopharmaceutical sectors for the production of organic possessions.   

The growth in biopharmaceutical development, the rising biomanufacturing infrastructure, the budding need for biopharmaceuticals, and headway in the single-use technologies are leading to the bourgeoning exigency of bioprocess bags. The applications of these bags include buffer and media handling, solid-liquid estrangement, and bioreactor rocking systems.  

• In 2023, an announcement was made by Merck that they launched the Ultimus Single-Use Process Container Film, which provides leak endurance and robustness when it comes to single-use bioprocess bags.  
• Sanisure has introduced Fill4Sure, which is a modified single-use container with advanced features like silicone overmolding and custom-designed needles used to restructure bioprocessing processes and facilitate industrialists in safeguarding supply chains.  

Bioprocess Bags Market: Stats and Figures  

• The market is expected to grow significantly during the coming years with 2D bioprocess bags making up more than 46.28% of the market.
• Bioprocess bags have improved due to advances in bag design. Preventing leaks saves US$ 50,000 - US$75,000 in costs during the buffering, media mixing and storage stage.
• Similarly, these advances save approximately US$ 375,000 during the intermediate mixing and storage stage, with highest impact at the transport and shipping of bulk drug substance stage with US$ 560,000 saved in average costs.
• According to comparative studies, 5-layer bags made of nylon/tie/EVOH/LLDPE polymers and structure register a hydrogen peroxide leak of less than 1 ppm (parts per million) compared to multi-layer PE bags, LLDPE bags, HDPE bags and laminated LLDPE bags. 

How AI Has Benefitted the Market  

Since the advent of AI and its advances, the bioprocess bags market has seen a massive changeover while changing the biotechnology sector for good. The manufacturing has become much smoother and ecological due to the efficiency, accuracy, and predictability of AI-powered systems.

• Automation: AI utilizes automation to simplify the production of bioprocess bags of differing sizes while delivering premium materials to the pharmaceutical industry.
• Supply chain management: AI algorithms can help in the prediction of stock, thus reducing the shortage and lessening supply costs.
• Ecological production: As AI-driven technologies can study and foretell the usage of materials, the production process becomes more sustainable by bringing down unwanted garbage.

Industry Leader Announcements  

• • Mr. Rainer M. Blair, President, CEO, & Director at Danaher Corporation:  

Reflecting on the growth of the Danaher Corporation in the monoclonal antibody (mAb) field, Blair said, “Monoclonal antibodies – which comprise more than 75% of our bioprocessing revenues – remain the largest investment area for our customers, and 2024 was a near record year of FDA [US Food and Drug Administration] approvals for new monoclonal antibodies.”  

Geographical Insights   

North America 

North America held a dominant share in the market in 2024. The increasing research and development projects and undertakings in the region due to the presence of several major biotechnology and pharmaceutical players is leading to significant demand for all laboratory equipment including bioprocess bags. The slowly rising costs of the clinical studies and biomedical research is leading to a rise in the incorporation of single-use bioprocessing bags. The growing contract manufacturing organizations (CMOs) sector in North America is also boosting demand for bioprocess bags market.

Asia Pacific 

The Asia Pacific bioprocess bags market is growing at a significant rate due to the increasing outsourcing of pharmaceutical research from other regions. This happens mainly due to the lower cost of conducting this research, clinical trials and also sponsoring drug development. The growing healthcare infrastructure and access to a diverse and large population makes Asia Pacific ideal for upcoming drug development and testing experiments. The region is expected to be an upcoming hub for biotechnology with governments and private investors in countries like China, India, South Korea, and Japan looking to invest and attract the biopharmaceutical industry, which is expected to drive the demand for bioprocess bags.

China 

The China bioprocess bags market is expanding, driven by government investments in biomedical and biotechnology, increasing production of biosimilars and biologics, along with a focus on optimized, cost-efficient synthesis and manufacturing practices is increasing the adoption of single-use systems.

Recent Developments:

• Sartorius, a leading company in single-use bioprocessing products, and McMaster University collaborated to open a firsthand bioprocessing automation lab at the university’s Faculty of Engineering in Ontario. With other industry associates, both students at McMaster and employees at Sartorius will be working on bioprocess modeling. 
• The leading suppliers of the biotechnology industry, Qosina and Entegris, have joined hands to present Aramus 2D bag chambers, which deliver outstanding cleanliness and improved security for vital fluids, consequently ensuring top-notch end products 

Competitive Landscape

The Bioprocess Bags Market presents a moderately consolidated competitive landscape, characterized by the dominance of a few key global players, though it is not entirely an oligopoly. Companies such as Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Danaher Corporation (via Cytiva), and Saint-Gobain Life Sciences occupy significant market shares due to their advanced manufacturing capabilities, strong brand equity, global distribution networks, and diversified product portfolios.

• Company Name: Corning Incorporated 
• Year of Incorporation: 1936 
• Headquarters: Corning, New York, United States 

Corning Incorporated engages in the optical communications, display technologies, environmental technologies, specialty materials, and life sciences businesses in the United States and internationally. The company's Life Sciences segment offers laboratory products, including consumables, such as plastic vessels, liquid handling plastics, specialty surfaces, cell culture media, and serum, as well as general labware, and glassware and equipment under the Corning, Pyrex, Falcon, and Axygen brands.

• Company Name: Thermo Fisher Scientific Inc.
• Year of Incorporation: 2006
• Headquarters:  Massachusetts, United States

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases.